Grapes and Vision

Chapter
First Online:

Abstract

Cataract, glaucoma, and age-related macular degeneration are frequent causes of blindness worldwide particularly in the elderly population. Continuous exposure to deleterious chemical agents in addition to an inadequate diet enhances oxidative stress in several tissues of the human eye and contributes to these and other ocular dysfunctions. Grapes contain a wide variety of phytochemicals that can function as cellular antioxidants and anti-inflammatory agents. Increased dietary intake of grapes or grape compounds may thus be effective in preventing or delaying the progression of these eye diseases. In this review, we focus on recent experimental, clinical, and epidemiological studies that support such beneficial properties of grape components on vision.

Keywords

Blindness Ocular pathologies Oxidative stress Eye Retina Vision Grapes Resveratrol Quercetin Lutein Zeaxanthin 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

This work was supported by research grants from the National Institutes of Health (R01-EY13295) and the Beckman Initiative for Macular Research by the Arnold and Mabel Beckman Foundation.

References

  1. Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, SanGiovanni J et al (2013) Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol 131:843–850CrossRefGoogle Scholar
  2. Amirul Islam FM, Chong EW, Hodge AM, Guymer RH, Aung KZ, Makeyeva GA, Baird PN, Hopper JL, English DR, Giles GG, Robman LD (2014) Dietary patterns and their associations with age-related macular degeneration: the Melbourne Collaborative Cohort Study. Ophthalmology 121:1428–1434CrossRefGoogle Scholar
  3. Arden GB, Sivaprasad S (2011) Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev 7:291–304CrossRefGoogle Scholar
  4. Arnal E, Miranda M, Almansa I, Muriach M, Barcia JM, Romero FJ, Diaz-Llopis M, Bosch-Morell F (2009) Lutein prevents cataract development and progression in diabetic rats. Graefes Arch Clin Exp Ophthalmol 247:115–120CrossRefGoogle Scholar
  5. Beatty S, Koh H-H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–134CrossRefGoogle Scholar
  6. Berendschot TT, Broekmans WM, Klopping-Ketelaars IA, Kardinaal AF, Van Poppel G, Van Norren D (2002) Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract. Arch Ophthalmol 120:1732–1737CrossRefGoogle Scholar
  7. Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W (2002) Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 109:1780–1787CrossRefGoogle Scholar
  8. Bhosale P, Li B, Sharifzadeh M, Gellermann W, Frederick JM, Tsuchida K, Bernstein PS (2009) Purification and partial characterization of a lutein-binding protein from human retina. Biochemistry 48:4798–4807CrossRefGoogle Scholar
  9. Bian Q, Gao S, Zhou J, Qin J, Taylor A, Johnson EJ, Tang G, Sparrow JR, Gierhart D, Shang F (2012) Lutein and zeaxanthin supplementation reduces photo-oxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells. Free Radic Biol Med 53:1298–1307CrossRefGoogle Scholar
  10. Bibb C, Young RW (1974) Renewal of fatty acids in the membranes of visual cell outer segments. J Cell Biol 61:327–343CrossRefGoogle Scholar
  11. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5:9–19CrossRefGoogle Scholar
  12. Bok D (1993) The retinal pigment epithelium: a versatile partner in vision. J Cell Sci 17:189–195CrossRefGoogle Scholar
  13. Bone RA, Landrum JT (1984) Macular pigment in Henle fiber membranes: a model for Haidinger’s brushes. Vision Res 24:103–108CrossRefGoogle Scholar
  14. Bone RA, Landrum JT, Tarsis SL (1985) Preliminary identification of the human macular pigment. Vision Res 25:1531–1535CrossRefGoogle Scholar
  15. Boots AW, Haenen GR, Bast A (2008) Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:325–337CrossRefGoogle Scholar
  16. Boulton M, Dayhaw-Barker P (2001) The role of the retinal pigment epithelium: topographical variation and ageing changes. Eye (Lond) 15:384–389CrossRefGoogle Scholar
  17. Boulton M, Moriarty P, Jarvis-Evans J, Marcyniuk B (1994) Regional variation and age-related changes of lysosomal enzymes in the human retinal pigment epithelium. Br J Ophthalmol 78:125–129CrossRefGoogle Scholar
  18. Bråkenhielm E, Cao R, Cao Y (2001) Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 15:1798–1800Google Scholar
  19. Brennan LA, Kantorow M (2009) Mitochondrial function and redox control in the aging eye: role of MsrA and other repair systems in cataract and macular degenerations. Exp Eye Res 88:195–203CrossRefGoogle Scholar
  20. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP (2000) Oxidative damage and protection of the RPE. Prog Retin Eye Res 19:205–221CrossRefGoogle Scholar
  21. Cao X, Liu M, Tuo J, Shen D, Chan CC (2010) The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Exp Eye Res 91:15–25CrossRefGoogle Scholar
  22. Carocho M, Ferreira IC (2013) A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem Toxicol 51:15–25CrossRefGoogle Scholar
  23. Cejkova J, Cejka C (2015) The role of oxidative stress in corneal diseases and injuries. Histol Histopathol 30(8):893–900Google Scholar
  24. Chen E, Soderberg PG, Lindstrom B (1992) Cytochrome oxidase activity in rat retina after exposure to 404 nm blue light. Curr Eye Res 11:825–831CrossRefGoogle Scholar
  25. Chen Y, Li X-X, Xing N-Z, Cao X-G (2008) Quercetin inhibits choroidal and retinal angiogenesis in vitro. Graefe’s Arch Clin Exp Ophthalmol 246:373–378CrossRefGoogle Scholar
  26. Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124–136CrossRefGoogle Scholar
  27. Chiu C-J, Chang M-L, Zhang FF, Li T, Gensler G, Schleicher M, Taylor A (2014) The relationship of major american dietary patterns to age-related macular degeneration. Am J Ophthalmol 158:118–127.e111CrossRefGoogle Scholar
  28. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd (2005) Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no. 19. Ophthalmology 112:533–539CrossRefGoogle Scholar
  29. Congdon N, O’Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122:477–485CrossRefGoogle Scholar
  30. D’Autreaux B, Toledano MB (2007) ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8:813–824CrossRefGoogle Scholar
  31. Decanini A, Nordgaard CL, Feng X, Ferrington DA, Olsen TW (2007) Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol 143:607–615CrossRefGoogle Scholar
  32. Del Priore LV, Kuo Y-H, Tezel TH (2002) Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest Ophthalmol Vis Sci 43:3312–3318Google Scholar
  33. Doganay S, Borazan M, Iraz M, Cigremis Y (2006) The effect of resveratrol in experimental cataract model formed by sodium selenite. Curr Eye Res 31:147–153CrossRefGoogle Scholar
  34. Doly M, Droy-Lefaix MT, Braquet P (1992) Oxidative stress in diabetic retina. EXS 62:299–307Google Scholar
  35. Dunaief JL, Dentchev T, Ying GS, Milam AH (2002) The role of apoptosis in age-related macular degeneration. Arch Ophthalmol 120:1435–1442CrossRefGoogle Scholar
  36. Eye Disease Case-control Study Group (1992) Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110:1701–1708CrossRefGoogle Scholar
  37. Feeney L (1978) Lipofuscin and melanin of human retinal pigment epithelium. Fluorescence, enzyme cytochemical, and ultrastructural studies. Invest Ophthalmol Vis Sci 17:583–600Google Scholar
  38. Feeney-Burns L, Hilderbrand ES, Eldridge S (1984) Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest Ophthalmol Vis Sci 25:195–200Google Scholar
  39. Feher J, Kovacs I, Artico M, Cavallotti C, Papale A, Balacco GC (2006) Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol Aging 27:983–993CrossRefGoogle Scholar
  40. Friedrichson T, Kalbach HL, Buck P, van Kuijk FJ (1995) Vitamin E in macular and peripheral tissues of the human eye. Curr Eye Res 14:693–701CrossRefGoogle Scholar
  41. Gehrs KM, Anderson DH, Johnson LV, Hageman GS (2006) Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann Med 38:450–471CrossRefGoogle Scholar
  42. Godley BF, Shamsi FA, Liang FQ, Jarrett SG, Davies S, Boulton M (2005) Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J Biol Chem 280:21061–21066CrossRefGoogle Scholar
  43. Ha JH, Shil PK, Zhu P, Gu L, Li Q, Chung S (2014) Ocular inflammation and endoplasmic reticulum stress are attenuated by supplementation with grape polyphenols in human retinal pigmented epithelium cells and in C57BL/6 mice. J Nutr 144(6):799–806CrossRefGoogle Scholar
  44. Hanneken A, Lin F-F, Johnson J, Maher P (2006) Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest Ophthalmol Vis Sci 47:3164–3177CrossRefGoogle Scholar
  45. He RR, Tsoi B, Lan F, Yao N, Yao XS, Kurihara H (2011) Antioxidant properties of lutein contribute to the protection against lipopolysaccharide-induced uveitis in mice. Chin Med 6:38CrossRefGoogle Scholar
  46. Heiba IM, Elston RC, Klein BE, Klein R (1994) Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol 11:51–67CrossRefGoogle Scholar
  47. Heijnen CG, Haenen GR, van Acker FA, van der Vijgh WJ, Bast A (2001) Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol In Vitro 15:3–6CrossRefGoogle Scholar
  48. Hightower KR, Duncan G, Dawson A, Wormstone IM, Reddan J, Dziedizc D (1999) Ultraviolet irradiation (UVB) interrupts calcium cell signaling in lens epithelial cells. Photochem Photobiol 69:595–598Google Scholar
  49. Higuchi A, Takahashi K, Hirashima M, Kawakita T, Tsubota K (2010) Selenoprotein P controls oxidative stress in cornea. PLoS One 5:e9911CrossRefGoogle Scholar
  50. Hosoya K, Tachikawa M (2012) The inner blood-retinal barrier: molecular structure and transport biology. Adv Exp Med Biol 763:85–104Google Scholar
  51. Hu BJ, Hu YN, Lin S, Ma WJ, Li XR (2011) Application of lutein and zeaxanthin in nonproliferative diabetic retinopathy. Int J Ophthalmol 4:303–306Google Scholar
  52. Hua J, Guerin KI, Chen J, Michán S, Stahl A, Krah NM, Seaward MR, Dennison RJ, Juan AM, Hatton CJ, Sapieha P, Sinclair DA, Smith LEH (2011) Resveratrol inhibits pathologic retinal neovascularization in vldlr−/− mice. Invest Ophthalmol Vis Sci 52:2809–2816CrossRefGoogle Scholar
  53. Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Umezawa K, Ohno S, Oike Y, Ishida S (2007) Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 27:2555–2562CrossRefGoogle Scholar
  54. Jin X-H, Ohgami K, Shiratori K, Suzuki Y, Hirano T, Koyama Y, Yoshida K, Ilieva I, Iseki K, Ohno S (2006) Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci 47:2562–2568CrossRefGoogle Scholar
  55. Jones MM, Manwaring N, Wang JJ, Rochtchina E, Mitchell P, Sue CM (2007) Mitochondrial DNA haplogroups and age-related maculopathy. Arch Ophthalmol 125:1235–1240CrossRefGoogle Scholar
  56. Jung T, Bader N, Grune T (2007) Lipofuscin. Ann NY Acad Sci 1119:97–111CrossRefGoogle Scholar
  57. Kanavi MR, Darjatmoko S, Wang S, Azari AA, Farnoodian M, Kenealey JD, van Ginkel PR, Albert DM, Sheibani N, Polans AS (2014) The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization. Molecules 19:17578–17603CrossRefGoogle Scholar
  58. Kanwar M, Chan P-S, Kern TS, Kowluru RA (2007) Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 48:3805–3811CrossRefGoogle Scholar
  59. Kim YH, Kim YS, Roh GS, Choi WS, Cho GJ (2012) Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas. Acta Ophthalmol 90:e31–e37CrossRefGoogle Scholar
  60. Kong GY, Van Bergen NJ, Trounce IA, Crowston JG (2009) Mitochondrial dysfunction and glaucoma. J Glaucoma 18:93–100CrossRefGoogle Scholar
  61. Kook D, Wolf AH, Yu AL, Neubauer AS, Priglinger SG, Kampik A, Welge-Lüssen UC (2008) The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol Vis Sci 49:1712–1720CrossRefGoogle Scholar
  62. Kowluru RA, Chan PS (2007) Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007:43603Google Scholar
  63. Kubota S, Kurihara T, Mochimaru H, Satofuka S, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K (2009) Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-κB activation. Invest Ophthalmol Vis Sci 50:3512–3519CrossRefGoogle Scholar
  64. Kuffler SW (1953) Discharge patterns and functional organization of mammalian retina. J Neurophysiol 16:37–68Google Scholar
  65. Landrum J, Bone R, Mendez V, Valenciaga A, Babino D (2012) Comparison of dietary supplementation with lutein diacetate and lutein: a pilot study of the effects on serum and macular pigment. Acta Biochim Pol 59:167–169Google Scholar
  66. Li C, Wang L, Huang K, Zheng L (2012) Endoplasmic reticulum stress in retinal vascular degeneration: protective role of resveratrol. Invest Ophthalmol Vis Sci 53:3241–3249CrossRefGoogle Scholar
  67. Liang FQ, Godley BF (2003) Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 76:397–403CrossRefGoogle Scholar
  68. Lou MF (2003) Redox regulation in the lens. Prog Retin Eye Res 22:657–682CrossRefGoogle Scholar
  69. Ma L, Dou HL, Huang YM, Lu XR, Xu XR, Qian F, Zou ZY, Pang HL, Dong PC, Xiao X, Wang X, Sun TT, Lin XM (2012a) Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial. Am J Ophthalmol 154:625–634.e621CrossRefGoogle Scholar
  70. Ma L, Yan SF, Huang YM, Lu XR, Qian F, Pang HL, Xu XR, Zou ZY, Dong PC, Xiao X, Wang X, Sun TT, Dou HL, Lin XM (2012b) Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology 119:2290–2297CrossRefGoogle Scholar
  71. Ma JH, Wang JJ, Zhang SX (2014) The unfolded protein response and diabetic retinopathy. J Diabetes Res 2014:14Google Scholar
  72. Miceli MV, Liles MR, Newsome DA (1994) Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. Exp Cell Res 214:242–249CrossRefGoogle Scholar
  73. Moeller SM, Voland R, Tinker L et al (2008) Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the carotenoids in the age-related eye disease study (CAREDS), an ancillary study of the women’s health initiative. Arch Ophthalmol 126:354–364CrossRefGoogle Scholar
  74. Moss SE, Klein R, Klein BE (2008) Long-term incidence of dry eye in an older population. Optom Vis Sci 85:668–674CrossRefGoogle Scholar
  75. Munoz B, West SK, Rubin GS, Schein OD, Quigley HA, Bressler SB, Bandeen-Roche K (2000) Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Arch Ophthalmol 118:819–825CrossRefGoogle Scholar
  76. Nandrot EF, Finnemann SC (2008) Lack of αvβ5 integrin receptor or its ligand MFG-E8: distinct effects on retinal function. Ophthalmic Res 40:120–123CrossRefGoogle Scholar
  77. Nandrot EF, Kim Y, Brodie SE, Huang X, Sheppard D, Finnemann SC (2004) Loss of synchronized retinal phagocytosis and age-related blindness in mice lacking αvβ5 integrin. J Exp Med 200:1539–1545CrossRefGoogle Scholar
  78. Newsholme P, Haber EP, Hirabara SM, Rebelato ELO, Procopio J, Morgan D, Oliveira-Emilio HC, Carpinelli AR, Curi R (2007) Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 583:9–24CrossRefGoogle Scholar
  79. Ng K-P, Gugiu B, Renganathan K, Davies MW, Gu X, Crabb JS, Kim SR, Różanowska MB, Bonilha VL, Rayborn ME, Salomon RG, Sparrow JR, Boulton ME, Hollyfield JG, Crabb JW (2008) Retinal pigment epithelium lipofuscin proteomics. Mol Cell Proteomics 7:1397–1405CrossRefGoogle Scholar
  80. Nilsson SE, Sundelin SP, Wihlmark U, Brunk UT (2003) Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage. Doc Ophthalmol 106:13–16CrossRefGoogle Scholar
  81. Nordgaard CL, Berg KM, Kapphahn RJ, Reilly C, Feng X, Olsen TW, Ferrington DA (2006) Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 47:815–822CrossRefGoogle Scholar
  82. Nordgaard CL, Karunadharma PP, Feng X, Olsen TW, Ferrington DA (2008) Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 49:2848–2855CrossRefGoogle Scholar
  83. O’Brien DF (1982) The chemistry of vision. Science 218:961–966CrossRefGoogle Scholar
  84. Oak AS, Messinger JD, Curcio CA (2014) Subretinal drusenoid deposits: further characterization by lipid histochemistry. Retina 34:825–826CrossRefGoogle Scholar
  85. Ohia SE, Opere CA, LeDay AM (2005) Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res 579:22–36CrossRefGoogle Scholar
  86. Owsley C, Huisingh C, Clark ME, Jackson GR, McGwin G (2016) Comparison of visual function in older eyes in the earliest stages of age-related macular degeneration to those in normal macular health. Curr Eye Res 41:266–272CrossRefGoogle Scholar
  87. Perry HD (2008) Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care 14:S79–S87Google Scholar
  88. Pintea A, Rugina D, Pop R, Bunea A, Socaciu C, Diehl HA (2011) Antioxidant effect of trans-resveratrol in cultured human retinal pigment epithelial cells. J Ocul Pharmacol Ther 27:315–321CrossRefGoogle Scholar
  89. Qin L, Bartlett H, Griffiths HR, Eperjesi F, Armstrong RA, Gherghel D (2011) Macular pigment optical density is related to blood glutathione levels in healthy individuals. Invest Ophthalmol Vis Sci 52:5029–5033CrossRefGoogle Scholar
  90. Rahman K (2007) Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2:219–236Google Scholar
  91. Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, Srivastava SK (2004) Activation of nuclear factor-κB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 53:2910–2920CrossRefGoogle Scholar
  92. Rapp LM, Maple SS, Choi JH (2000) Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci 41:1200–1209Google Scholar
  93. Read MA (1995) Flavonoids: naturally occurring anti-inflammatory agents. Am J Pathol 147:235–237Google Scholar
  94. Reddan JR, Giblin FJ, Kadry R, Leverenz VR, Pena JT, Dziedzic DC (1999) Protection from oxidative insult in glutathione depleted lens epithelial cells. Exp Eye Res 68:117–127CrossRefGoogle Scholar
  95. Romeo G, Liu W-H, Asnaghi V, Kern TS, Lorenzi M (2002) Activation of nuclear factor-κB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241–2248CrossRefGoogle Scholar
  96. Ruggiero L, Finnemann SC (2014) Photoreceptor-RPE interactions: diurnal phagocytosis. In: Werner JS, Chalupa LM (eds) The new visual neurosciences. MIT Press, Cambridge, MAGoogle Scholar
  97. Ruggiero L, Connor MP, Chen J, Langen R, Finnemann SC (2012) Diurnal, localized exposure of phosphatidylserine by rod outer segment tips in wild-type but not Itgb5−/− or Mfge8−/− mouse retina. Proc Natl Acad Sci USA 109:8145–8148CrossRefGoogle Scholar
  98. Sacca SC, Izzotti A (2008) Oxidative stress and glaucoma: injury in the anterior segment of the eye. Prog Brain Res 173:385–407CrossRefGoogle Scholar
  99. SanGiovanni JP, Arking DE, Iyengar SK, Elashoff M, Clemons TE, Reed GF, Henning AK, Sivakumaran TA, Xu X, DeWan A, Agron E, Rochtchina E, Sue CM, Wang JJ, Mitchell P, Hoh J, Francis PJ, Klein ML, Chew EY, Chakravarti A (2009) Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS One 4:e5508CrossRefGoogle Scholar
  100. Sasaki M, Ozawa Y, Kurihara T, Noda K, Imamura Y, Kobayashi S, Ishida S, Tsubota K (2009) Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci 50:1433–1439CrossRefGoogle Scholar
  101. Sasaki M, Ozawa Y, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K (2010) Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia 53:971–979CrossRefGoogle Scholar
  102. Schaumberg DA, Sullivan DA, Buring JE, Dana MR (2003) Prevalence of dry eye syndrome among US women. Am J Ophthalmol 136:318–326CrossRefGoogle Scholar
  103. Schmidt SY, Peisch RD (1986) Melanin concentration in normal human retinal pigment epithelium. Regional variation and age-related reduction. Invest Ophthalmol Vis Sci 27:1063–1067Google Scholar
  104. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT et al (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-control Study Group. JAMA 272:1413–1420CrossRefGoogle Scholar
  105. Simpkins JW, Wang J, Wang X, Perez E, Prokai L, Dykens JA (2005) Mitochondria play a central role in estrogen-induced neuroprotection. Curr Drug Targets CNS Neurol Disord 4:69–83CrossRefGoogle Scholar
  106. Soufi FG, Mohammad-Nejad D, Ahmadieh H (2012) Resveratrol improves diabetic retinopathy possibly through oxidative stress—nuclear factor kappaB—apoptosis pathway. Pharmacol Rep 64:1505–1514CrossRefGoogle Scholar
  107. Sparrow JR, Yamamoto K (2012) The bisretinoids of RPE lipofuscin: a complex mixture. Adv Exp Med Biol 723:761–767CrossRefGoogle Scholar
  108. Sparrow JR, Gregory-Roberts E, Yamamoto K, Blonska A, Ghosh SK, Ueda K, Zhou J (2012) The bisretinoids of retinal pigment epithelium. Prog Retin Eye Res 31:121–135CrossRefGoogle Scholar
  109. Spector A (1995) Oxidative stress-induced cataract: mechanism of action. FASEB J 9:1173–1182Google Scholar
  110. Sundelin SP, Nilsson SEG (2001) Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic Biol Med 31:217–225CrossRefGoogle Scholar
  111. Surguchev A, Surguchov A (2010) Conformational diseases: looking into the eyes. Brain Res Bull 81:12–24CrossRefGoogle Scholar
  112. Tate DJ, Miceli MV, Newsome DA (1995) Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 36:1271–1279Google Scholar
  113. Tezel G (2006) Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25:490–513CrossRefGoogle Scholar
  114. Tuo J, Bojanowski CM, Zhou M, Shen D, Ross RJ, Rosenberg KI, Cameron DJ, Yin C, Kowalak JA, Zhuang Z, Zhang K, Chan C-C (2007) Murine Ccl2/Cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci 48:3827–3836CrossRefGoogle Scholar
  115. Uchino Y, Kawakita T, Ishii T, Ishii N, Tsubota K (2012) A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland. Cornea 31:S63–S67CrossRefGoogle Scholar
  116. Udar N, Atilano SR, Memarzadeh M, Boyer DS, Chwa M, Lu S, Maguen B, Langberg J, Coskun P, Wallace DC, Nesburn AB, Khatibi N, Hertzog D, Le K, Hwang D, Kenney MC (2009) Mitochondrial DNA haplogroups associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 50:2966–2974CrossRefGoogle Scholar
  117. van Acker SA, Tromp MN, Haenen GR, van der Vijgh WJ, Bast A (1995) Flavonoids as scavengers of nitric oxide radical. Biochem Biophys Res Commun 214:755–759CrossRefGoogle Scholar
  118. Vingerling JR, Klaver CC, Hofman A, de Jong PT (1995) Epidemiology of age-related maculopathy. Epidemiol Rev 17:347–360Google Scholar
  119. Wade NJ (2007) Image, eye, and retina. J Opt Soc Am A 24:1229–1249CrossRefGoogle Scholar
  120. Wang AL, Lukas TJ, Yuan M, Neufeld AH (2008) Increased mitochondrial DNA damage and down-regulation of DNA repair enzymes in aged rodent retinal pigment epithelium and choroid. Mol Vis 14:644–651Google Scholar
  121. Weigert G, Kaya S, Pemp B, Sacu S, Lasta M, Werkmeister RM, Dragostinoff N, Simader C, Garhöfer G, Schmidt-Erfurth U, Schmetterer L (2011) Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 52:8174–8178CrossRefGoogle Scholar
  122. Weiter JJ, Delori FC, Wing GL, Fitch KA (1986) Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 27:145–152Google Scholar
  123. Whiteside CI (2005) Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species. Curr Hypertens Rep 7:148–154CrossRefGoogle Scholar
  124. Wink DA, Wink CB, Nims RW, Ford PC (1994) Oxidizing intermediates generated in the Fenton reagent: kinetic arguments against the intermediacy of the hydroxyl radical. Environ Health Perspect 102:11–15CrossRefGoogle Scholar
  125. Yao K, Zhang L, Ye PP, Tang XJ, Zhang YD (2009) Protective effect of magnolol against hydrogen peroxide-induced oxidative stress in human lens epithelial cells. Am J Chin Med 37:785–796CrossRefGoogle Scholar
  126. Yeum KJ, Taylor A, Tang G, Russell RM (1995) Measurement of carotenoids, retinoids, and tocopherols in human lenses. Invest Ophthalmol Vis Sci 36:2756–2761Google Scholar
  127. Yu C-C, Nandrot EF, Dun Y, Finnemann SC (2012) Dietary antioxidants prevent age-related retinal pigment epithelium actin damage and blindness in mice lacking αvβ5 integrin. Free Radic Biol Med 52:660–670CrossRefGoogle Scholar
  128. Zerbib J, Seddon JM, Richard F, Reynolds R, Leveziel N, Benlian P, Borel P, Feingold J, Munnich A, Soubrane G, Kaplan J, Rozet JM, Souied EH (2009) rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One 4(10):e7341CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Biological Sciences, Center for Cancer, Genetic Diseases and Gene RegulationFordham UniversityBronxUSA

Personalised recommendations